[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Metsera, Inc. Common Stock (MTSR) Pfizer acquires Metsera for $XXX billion, sending MTSR shares soaring. The deal gives Pfizer a foothold in the booming obesity treatment market. ### About Metsera, Inc. Common Stock Metsera, Inc. Common Stock (MTSR) is a stock of a company focused on developing protein drugs for obesity treatment. Metsera, Inc. Common Stock uses the ticker $MTSR for trading. Listed in the [Stocks](/list/stocks) and category. ### Insights [#](/topic/$mtsr/insights) - Metsera, Inc. Common Stock (MTSR) social dominance is up XXX% from the previous month. - Metsera, Inc. Common Stock (MTSR) galaxy score™ is up XXXXX% from the previous month. ### Price: $XXXXX [#](/topic/$mtsr/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/close.tsv) The price action is likely driven by the Pfizer acquisition news, with the stock price hitting a 52-week high. The positive sentiment from the acquisition and the potential of Metsera's pipeline are likely contributing to the price increase. | 24-Hour | 7-Day | 30-Day | | ------- | ----- | ------ | | -XXXX% | XXXX% | XXXXX% | **1-Year High**: $XXXXX on 2025-09-22 **1-Year Low**: $XXXXX on 2025-04-10 ### AltRank: XXXXX [#](/topic/$mtsr/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/alt_rank.tsv) Metsera, Inc. Common Stock (MTSR) is currently AltRank #1,331 based on combined combined social and market metrics **Daily Average**: XXXXX **1 Week**: XXX +287 **1 Month**: XXXXX -XXX **6 Months**: XXXXX +1,115 **1 Year**: XXXXX -XXX **1-Year High**: XXXXX on 2025-07-28 **1-Year Low**: XX on 2025-09-22 ### Galaxy Score: XXXXX [#](/topic/$mtsr/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/galaxy_score.tsv) **Current Value**: XXXXX **Daily Average**: XX **1 Week**: XX +21 **1 Month**: XX +35 **6 Months**: XX +3 **1 Year**: XX +34 **1-Year High**: XX on 2025-09-22 **1-Year Low**: XX on 2025-05-09 ### Engagements: XXXXX [#](/topic/$mtsr/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/interactions.tsv) **Current Value**: XXXXX **Daily Average**: XXXXXX **1 Week**: XXXXXX -XX% **1 Month**: XXXXXXXXX +393% **6 Months**: XXXXXXXXX +371% **1 Year**: XXXXXXXXX +307% **1-Year High**: XXXXXXX on 2025-09-22 **1-Year Low**: X on 2024-10-26 | Social Network | X | Reddit | | -------------- | - | ------ | | Engagements | XXXXX | XX | ### Mentions: XX [#](/topic/$mtsr/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: XX **1 Month**: XXXXX +343% **6 Months**: XXXXX +823% **1 Year**: XXXXX +13,474% **1-Year High**: XXXXX on 2025-09-23 **1-Year Low**: X on 2024-10-26 | Social Network | X | Reddit | | -------------- | - | ------ | | Mentions | XXX | X | ### Creators: XX [#](/topic/$mtsr/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Metsera, Inc. Common Stock (MTSR) in the last XX hours which is up XX% from XX in the previous XX hours **Daily Average**: XX **1 Month**: XXX +419% **6 Months**: XXXXX +1,163% **1 Year**: XXXXX +9,322% **1-Year High**: XXXXX on 2025-09-23 **1-Year Low**: X on 2024-10-22 The most influential creators that mention Metsera, Inc. Common Stock in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@PersimmonTI](/creator/twitter/PersimmonTI) | X | XXXXXX | X | XXXXX | | [@JoseRestonVA](/creator/twitter/JoseRestonVA) | X | XXXXX | X | XXX | | [@Biotech2k1](/creator/twitter/Biotech2k1) | X | XXXXXX | X | XXX | | [@GilaMonstrum](/creator/twitter/GilaMonstrum) | X | XXXXX | X | XXX | | [@MeadowCapital](/creator/twitter/MeadowCapital) | X | XXXXX | X | XXX | | [@SamFazeli8](/creator/twitter/SamFazeli8) | X | XXXXX | X | XXX | | [@Optimistic24228](/creator/twitter/Optimistic24228) | X | XXX | X | XXX | | [@prasadchoragud1](/creator/twitter/prasadchoragud1) | X | | X | XX | | [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X | XXXXXX | X | XX | | [@jfais20](/creator/twitter/jfais20) | XX | XXXXXX | X | XX | [View More](/list/creators/$mtsr/100) ### Sentiment: XX% [#](/topic/$mtsr/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XX% -XX% **1 Month**: XX% -XX% **6 Months**: XX% -XX% **1 Year**: XX% -XX% **1-Year High**: XXX% on 2024-11-20 **1-Year Low**: XX% on 2025-01-13 **Most Supportive Themes** - **Pfizer Acquisition:** (55%) Pfizer's acquisition of Metsera is viewed as a major positive, injecting capital and resources into the company's obesity drug pipeline. - **Positive Data and Pipeline:** (25%) The potential of Metsera's lead drug and other molecules in the clinic, along with the company's innovative technology, are highlighted as key strengths. - **Market Opportunity:** (10%) The booming obesity treatment market and the potential for Metsera to capture a significant share are driving positive sentiment. **Most Critical Themes** - **Valuation Concerns:** (5%) Some investors question whether the acquisition price is justified, especially compared to the valuations of other companies in the space. - **Competition:** (5%) The competitive landscape in the obesity drug market, with established players like Eli Lilly and Novo Nordisk, poses a challenge. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXXXX | XX% | XXXXX | XX% | XXX | X% | | Reddit | X | X% | XX | X% | X | X% | | | | | | | | | | Total | XXXXX | XX% | XXXXX | XX% | XXX | X% | ### Social Dominance: XXXXX% [#](/topic/$mtsr/social_dominance) ---  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/social_dominance.tsv) **Current Value**: XXXXX% **Daily Average**: XXXXX% **1 Week**: XXXXX% +0.003% **1 Month**: XXXXX% +0.014% **6 Months**: XXXXX% +0.0075% **1 Year**: XXXXX% +0.016% **1-Year High**: XXXXX% on 2025-09-23 **1-Year Low**: XXXXXX% on 2024-12-07 ### Market Dominance: XXXXXXX% [#](/topic/$mtsr/market_dominance) ---  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/market_dominance.tsv) **Current Value**: XXXXXXX% **Daily Average**: X% **1-Year High**: XXXXX% on 2025-03-31 **1-Year Low**: XXXXXXX% on 2025-04-10 ### Market Cap: $XXXXXXXXXXXXX [#](/topic/$mtsr/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/market_cap.tsv) **Current Value**: $XXXXXXXXXXXXX **Daily Average**: $XXXXXXXXXXXXX **1 Week**: $XXXXXXXXXXXXX +$1.30% **1 Month**: $XXXXXXXXXXXXX +$59% **6 Months**: $XXXXXXXXXXXXX +$145% **1-Year High**: $XXXXXXXXXXXXX on 2025-09-22 **1-Year Low**: $XXXXXXXXXXXXX on 2025-04-10 **Top assets mentioned** In the posts about Metsera, Inc. Common Stock in the last XX hours [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Pfizer, Inc. (PFE)](/topic/$pfe) [Novo-Nordisk (NVO)](/topic/$nvo) [Akropolis (AKRO)](/topic/$akro) [Bitcoin Incognito (XBI)](/topic/$xbi) [Eli Lilly and Company (LLY)](/topic/eli-lilly) [Merus N.V. Common Shares (MRUS)](/topic/$mrus) [Merck & Co., Inc. (MRK)](/topic/$mrk) [AbbVie Inc (ABBV)](/topic/$abbv) **Top topics mentioned** In the posts about Metsera, Inc. Common Stock in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [$vktx](/topic/$vktx), [$pfe](/topic/$pfe), [$nvo](/topic/$nvo), [acquisition](/topic/acquisition), [$gpcr](/topic/$gpcr), [$akro](/topic/$akro), [$xbi](/topic/$xbi), [eli lilly](/topic/eli-lilly), [$psnl](/topic/$psnl), [stocks technology](/topic/stocks-technology), [$mrus](/topic/$mrus), [$etnb](/topic/$etnb), [$mrk](/topic/$mrk), [stocks](/topic/stocks), [$abbv](/topic/$abbv), [investment](/topic/investment), [$cytk](/topic/$cytk), [$oklo](/topic/$oklo), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [weight loss](/topic/weight-loss), [$amgn](/topic/$amgn), [has been](/topic/has-been), [$bbio](/topic/$bbio), [chopped](/topic/chopped), [$abvx](/topic/$abvx), [$mens](/topic/$mens), [$10b](/topic/$10b), [$375b](/topic/$375b), [$808m](/topic/$808m), [$trml](/topic/$trml), [$mdgl](/topic/$mdgl), [$rna](/topic/$rna), [$apge](/topic/$apge), [behind the](/topic/behind-the), [market cap](/topic/market-cap), [$geos](/topic/$geos), [$indi](/topic/$indi), [coins made in usa](/topic/coins-made-in-usa), [coins base ecosystem](/topic/coins-base-ecosystem), [coins arbitrum](/topic/coins-arbitrum), [money](/topic/money), [united therapeutics corp](/topic/united-therapeutics-corp), [$uthr](/topic/$uthr), [$mngl](/topic/$mngl), [$insm](/topic/$insm), [$axm](/topic/$axm), [$crnx](/topic/$crnx), [$celh](/topic/$celh), [$fcx](/topic/$fcx), [$smtc](/topic/$smtc), [$bmy](/topic/$bmy), [$csan](/topic/$csan), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$qubt](/topic/$qubt), [bitmine](/topic/bitmine), [$nbi](/topic/$nbi), [$lly](/topic/$lly), [$agio](/topic/$agio), [$btsg](/topic/$btsg), [$crsp](/topic/$crsp), [$ehc](/topic/$ehc), [$gh](/topic/$gh), [$ptgx](/topic/$ptgx), [johnson johnson](/topic/johnson-johnson), [$jnj](/topic/$jnj), [$prax](/topic/$prax), [$nvts](/topic/$nvts), [$actu](/topic/$actu), [$alms](/topic/$alms), [$bhc](/topic/$bhc), [bolt token](/topic/bolt-token), [coins](/topic/coins), [$orcl](/topic/$orcl), [$gpc](/topic/$gpc), [$coop](/topic/$coop), [novartis](/topic/novartis), [$ssrm](/topic/$ssrm), [autocrypto](/topic/autocrypto), [coins bsc](/topic/coins-bsc), [coins ai](/topic/coins-ai), [$au](/topic/$au), [$gubra](/topic/$gubra), [china](/topic/china), [$bntx](/topic/$bntx), [$bny](/topic/$bny), [$smmt](/topic/$smmt), [$idya](/topic/$idya), [doc](/topic/doc), [patience](/topic/patience), [$amg](/topic/$amg), [$sony](/topic/$sony), [$mo](/topic/$mo), [$rprx](/topic/$rprx), [$puk](/topic/$puk), [$azn](/topic/$azn), [$joby](/topic/$joby), [$16b](/topic/$16b), [$frsh](/topic/$frsh), [$asts](/topic/$asts) ### Top Social Posts [#](/topic/$mtsr/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$XBI Selected Therapies in Development for Obesity Courtesy the incomparable @NatRevDrugDisc (Editor: and pre $MTSR buyout by $PFE) " [X Link](https://x.com/PersimmonTI/status/1979900758955868313) [@PersimmonTI](/creator/x/PersimmonTI) 2025-10-19T13:21Z 10.3K followers, 1859 engagements "@PGainz96934 You already lost. I am trying to tell you why. Good luck though. I was in $MTSR because they are a really good obesity company. Now I am out with XXX% gain. I don't mind the worse investor if I am making XXX% gains" [X Link](https://x.com/Biotech2k1/status/1979882333827461440) [@Biotech2k1](/creator/x/Biotech2k1) 2025-10-19T12:08Z 32.4K followers, XX engagements "Air Taxi $BETA IPO Eyes XXXX Billion Valuation **Other Leading New Issues This Year $MENS $CRCL $CRWV $KRMN $MTSR $AAPG $MIAX $WYFI" [X Link](https://x.com/STaylor76084368/status/1979643980859248715) [@STaylor76084368](/creator/x/STaylor76084368) 2025-10-18T20:21Z XXX followers, XXX engagements "Best stock advice right now Investing in zero revenues unicorns. YEAR-TO-DATE HEAT MAP OF STOCKS WITH $1B+ MARKET CAP & $1M REVENUES $OKLO +642% $JOBY +98% $CALC -X% $NEUP +417% $SNSE +3313% $MTSR +99% $QUBT 0%" [X Link](https://x.com/ValueSense_io/status/1979366868885328152) [@ValueSense_io](/creator/x/ValueSense_io) 2025-10-18T02:00Z 42.5K followers, 3463 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Pfizer acquires Metsera for $XXX billion, sending MTSR shares soaring. The deal gives Pfizer a foothold in the booming obesity treatment market.
Metsera, Inc. Common Stock (MTSR) is a stock of a company focused on developing protein drugs for obesity treatment.
Metsera, Inc. Common Stock uses the ticker $MTSR for trading. Listed in the Stocks and category.
Price 24-Hour Time-Series Raw Data
The price action is likely driven by the Pfizer acquisition news, with the stock price hitting a 52-week high. The positive sentiment from the acquisition and the potential of Metsera's pipeline are likely contributing to the price increase.
24-Hour | 7-Day | 30-Day |
---|---|---|
-XXXX% | XXXX% | XXXXX% |
1-Year High: $XXXXX on 2025-09-22
1-Year Low: $XXXXX on 2025-04-10
AltRank 24-Hour Time-Series Raw Data
Metsera, Inc. Common Stock (MTSR) is currently AltRank #1,331 based on combined combined social and market metrics
Daily Average: XXXXX
1 Week: XXX +287
1 Month: XXXXX -XXX
6 Months: XXXXX +1,115
1 Year: XXXXX -XXX
1-Year High: XXXXX on 2025-07-28
1-Year Low: XX on 2025-09-22
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +21
1 Month: XX +35
6 Months: XX +3
1 Year: XX +34
1-Year High: XX on 2025-09-22
1-Year Low: XX on 2025-05-09
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXXXX +393%
6 Months: XXXXXXXXX +371%
1 Year: XXXXXXXXX +307%
1-Year High: XXXXXXX on 2025-09-22
1-Year Low: X on 2024-10-26
Social Network | X | |
---|---|---|
Engagements | XXXXX | XX |
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XXXXX +343%
6 Months: XXXXX +823%
1 Year: XXXXX +13,474%
1-Year High: XXXXX on 2025-09-23
1-Year Low: X on 2024-10-26
Social Network | X | |
---|---|---|
Mentions | XXX | X |
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Metsera, Inc. Common Stock (MTSR) in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
1 Month: XXX +419%
6 Months: XXXXX +1,163%
1 Year: XXXXX +9,322%
1-Year High: XXXXX on 2025-09-23
1-Year Low: X on 2024-10-22
The most influential creators that mention Metsera, Inc. Common Stock in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@PersimmonTI | X | XXXXXX | X | XXXXX |
@JoseRestonVA | X | XXXXX | X | XXX |
@Biotech2k1 | X | XXXXXX | X | XXX |
@GilaMonstrum | X | XXXXX | X | XXX |
@MeadowCapital | X | XXXXX | X | XXX |
@SamFazeli8 | X | XXXXX | X | XXX |
@Optimistic24228 | X | XXX | X | XXX |
@prasadchoragud1 | X | X | XX | |
@BiopharmIQ | X | XXXXXX | X | XX |
@jfais20 | XX | XXXXXX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -XX%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-11-20
1-Year Low: XX% on 2025-01-13
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXXXX | XX% | XXXXX | XX% | XXX | X% |
X | X% | XX | X% | X | X% | |
Total | XXXXX | XX% | XXXXX | XX% | XXX | X% |
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.003%
1 Month: XXXXX% +0.014%
6 Months: XXXXX% +0.0075%
1 Year: XXXXX% +0.016%
1-Year High: XXXXX% on 2025-09-23
1-Year Low: XXXXXX% on 2024-12-07
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-04-10
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$1.30%
1 Month: $XXXXXXXXXXXXX +$59%
6 Months: $XXXXXXXXXXXXX +$145%
1-Year High: $XXXXXXXXXXXXX on 2025-09-22
1-Year Low: $XXXXXXXXXXXXX on 2025-04-10
Top assets mentioned In the posts about Metsera, Inc. Common Stock in the last XX hours
Viking Therapeutics, Inc (VKTX) Pfizer, Inc. (PFE) Novo-Nordisk (NVO) Akropolis (AKRO) Bitcoin Incognito (XBI) Eli Lilly and Company (LLY) Merus N.V. Common Shares (MRUS) Merck & Co., Inc. (MRK) AbbVie Inc (ABBV)
Top topics mentioned In the posts about Metsera, Inc. Common Stock in the last XX hours
stocks healthcare, $vktx, $pfe, $nvo, acquisition, $gpcr, $akro, $xbi, eli lilly, $psnl, stocks technology, $mrus, $etnb, $mrk, stocks, $abbv, investment, $cytk, $oklo, stocks consumer cyclical, weight loss, $amgn, has been, $bbio, chopped, $abvx, $mens, $10b, $375b, $808m, $trml, $mdgl, $rna, $apge, behind the, market cap, $geos, $indi, coins made in usa, coins base ecosystem, coins arbitrum, money, united therapeutics corp, $uthr, $mngl, $insm, $axm, $crnx, $celh, $fcx, $smtc, $bmy, $csan, stocks bitcoin treasuries, $qubt, bitmine, $nbi, $lly, $agio, $btsg, $crsp, $ehc, $gh, $ptgx, johnson johnson, $jnj, $prax, $nvts, $actu, $alms, $bhc, bolt token, coins, $orcl, $gpc, $coop, novartis, $ssrm, autocrypto, coins bsc, coins ai, $au, $gubra, china, $bntx, $bny, $smmt, $idya, doc, patience, $amg, $sony, $mo, $rprx, $puk, $azn, $joby, $16b, $frsh, $asts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$XBI Selected Therapies in Development for Obesity Courtesy the incomparable @NatRevDrugDisc (Editor: and pre $MTSR buyout by $PFE) "
X Link @PersimmonTI 2025-10-19T13:21Z 10.3K followers, 1859 engagements
"@PGainz96934 You already lost. I am trying to tell you why. Good luck though. I was in $MTSR because they are a really good obesity company. Now I am out with XXX% gain. I don't mind the worse investor if I am making XXX% gains"
X Link @Biotech2k1 2025-10-19T12:08Z 32.4K followers, XX engagements
"Air Taxi $BETA IPO Eyes XXXX Billion Valuation **Other Leading New Issues This Year $MENS $CRCL $CRWV $KRMN $MTSR $AAPG $MIAX $WYFI"
X Link @STaylor76084368 2025-10-18T20:21Z XXX followers, XXX engagements
"Best stock advice right now Investing in zero revenues unicorns. YEAR-TO-DATE HEAT MAP OF STOCKS WITH $1B+ MARKET CAP & $1M REVENUES $OKLO +642% $JOBY +98% $CALC -X% $NEUP +417% $SNSE +3313% $MTSR +99% $QUBT 0%"
X Link @ValueSense_io 2025-10-18T02:00Z 42.5K followers, 3463 engagements
/topic/$mtsr